Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 2—February 2012

Research

Effect of Surveillance Method on Reported Characteristics of Lyme Disease, Connecticut, 1996–2007

Starr-Hope ErtelComments to Author , Randall S. Nelson, and Matthew L. Cartter
Author affiliations: Connecticut Department of Public Health, Hartford, Connecticut, USA

Main Article

Table 3

Clinical manifestations of Lyme disease, by surveillance method, Connecticut, 1996–2007*

Clinical manifestations No. (%) cases
PS, n = 12,185 AS, n = 8,666 ELS, n = 1,949 MLS, n = 10,657 Total, n = 33,457
Erythema migrans only 9,489 (77.9) 6,324 (73.0) 1,032 (53.0) 5,305 (49.8) 22,150 (66.2)
Late manifestations only 2,059 (16.9) 1,725 (19.9) 763 (39.1) 4,678 (43.9) 9,225 (27.6)
Both 637 (5.2) 617 (7.1) 154 (7.9) 674 (6.3) 2,082 (6.2)

*PS, passive surveillance; AS, active surveillance; ELS, enhanced laboratory surveillance; MLS, mandatory laboratory surveillance.

Main Article

TOP